Rayner, a United Kingdom-based medical device manufacturer, has acquired Swiss-based firm, This (Think in System) AG, the inventor, developer and manufacturer of Sophi phaco emulsification machines.

The acquisition enhances Rayner’s breadth of high-quality products for cataract surgery, which includes intraocular lenses, ophthalmic viscosurgical devices, eye drops, pharmaceuticals, digital tools, and single-use recyclable instruments.

Sophi (Swiss Ophthalmology Innovation) is an innovative phaco technology. Playing a central role in cataract surgery, it provides mobility, simplicity, and safety within the operating theatre. Features include triple pump fluidics, active intraocular pressure control, clean venturi and day cassette, cable free power supply, and wireless communication.

“At Rayner we aspire to launch the highest quality products, inspired by surgeons and driven by science. Sophi shares this vision, and their machines are truly differentiated with breakthrough technology combined with stunning design which makes them such a good fit for Rayner,” said Tim Clover, Rayner CEO. “I’m excited about their product range today, as well as what we will be planning together for tomorrow.”

Thomas Koeppel, Founder and CEO of Sophi, said “Sophi was created by viewing things from a completely new perspective: to redefine the requirements of a perfect phaco system by focussing on the point of view of the surgeon and their team. We saw the same philosophy in Rayner and are excited to combine in order to offer Sophi through an expanded commercial team and to accelerate our innovation projects.”